Stockholders’ Equity (Deficit) (Details) - USD ($)														3 Months Ended		9 Months Ended
	Mar. 28, 2023	Mar. 23, 2023	Mar. 09, 2023	Feb. 28, 2023	Feb. 21, 2023	Feb. 14, 2023	Jan. 23, 2023	Nov. 07, 2022	Apr. 18, 2022	Mar. 31, 2022	Mar. 31, 2022	Jan. 12, 2022	Jan. 05, 2022	Mar. 31, 2023	Mar. 31, 2022	Sep. 30, 2022	Dec. 31, 2022	Nov. 18, 2022	Mar. 18, 2022
Stockholders’ Equity (Deficit) (Details) [Line Items]
Common Stock, Shares Authorized (in Shares)														500,000,000			500,000,000
Common Stock, Par or Stated Value Per Share (in Dollars per share)												$ 0.01		$ 0.01			$ 0.01
Common Stock, Shares, Issued (in Shares)														4,995,573			4,630,372
Common Stock, Shares, Outstanding (in Shares)														4,995,573			4,630,372
Stock Issued During Period, Shares, Issued for Services (in Shares)					150,000		150,000
Shares Issued, Price Per Share (in Dollars per share)					$ 2.53		$ 3.45							$ 4.38
Share-Based Payment Arrangement, Expense					$ 379,500		$ 517,500
Debt Conversion, Converted Instrument, Shares Issued (in Shares)				13,555										57,138
Accrued Salaries, Current												$ 19,032
Shares Issued, Shares, Share-Based Payment Arrangement, Forfeited (in Shares)												8,000
Shares Issued, Value, Share-Based Payment Arrangement, Forfeited												$ 4,000
Gains (Losses) on Restructuring of Debt												$ 15,032		$ 0	$ 15,032
Other Accrued Liabilities, Current														0			$ 507
Other Noncash Expense														1,102,778	0
														0	198,273
Debt Instrument, Unamortized Discount														$ 8,472			$ 32,041
Preferred Stock, Shares Authorized (in Shares)														100,000,000
Dividends, Preferred Stock														$ 79,818	$ 79,692
Preferred Stock, Convertible, Terms								Each share of Series E shall become convertible, at the option of the holder, commencing on the date of issuance, into such number of fully paid and non-assessable shares of Common Stock. The conversion price shall be, as of the conversion date, (a) prior to the date of the qualified offering the average VWAP per share of the Common Stock for the five (5) trading days prior to the date of conversion and (b) on or following the date of the qualified offering, the qualified offering price (the “Conversion Price”). Immediately following the 120th day following the qualified offering, the Conversion Price shall be adjusted to the lesser of (a) the average VWAP per share of the Common Stock for the five (5) trading days immediately following the 120th day following the qualified offering and (b) the Conversion Price on such date, which shall in no event be less than $0.05.
Preferred Stock, Convertible, Conversion Price (in Dollars per share)								$ 0.05
Stock Subscribed [Member]
Stockholders’ Equity (Deficit) (Details) [Line Items]
Shares Issued, Price Per Share (in Dollars per share)										$ 12.5	$ 12.5				$ 12.5
Stock Issued During Period, Shares, Other (in Shares)											7,647
GS Capital Note [Member]
Stockholders’ Equity (Deficit) (Details) [Line Items]
Debt Conversion, Original Debt, Amount														$ 72,777
Debt Instrument, Convertible, Conversion Price (in Dollars per share)	$ 1.25		$ 1.5	$ 1.5		$ 1.74								$ 1.46
Debt Conversion, Converted Instrument, Shares Issued (in Shares)	18,472		15,265			9,846
Stock Issued During Period, Shares, Other (in Shares)									12,741
Derivative Liability									$ 21,920
Debt Instrument, Unamortized Discount									$ 162,158
GS Capital Note [Member] | Principal [Member]
Stockholders’ Equity (Deficit) (Details) [Line Items]
Debt Conversion, Original Debt, Amount	$ 20,000		$ 20,000	$ 17,777		$ 15,000
GS Capital Note [Member] | Accrued Interest [Member]
Stockholders’ Equity (Deficit) (Details) [Line Items]
Debt Conversion, Original Debt, Amount	2,581		2,399	2,057		1,632								$ 8,679
GS Capital Note [Member] | Fees [Member]
Stockholders’ Equity (Deficit) (Details) [Line Items]
Debt Conversion, Original Debt, Amount	$ 500		$ 500	$ 500		$ 500								$ 2,000
Series X Preferred Stock [Member]
Stockholders’ Equity (Deficit) (Details) [Line Items]
Stock Issued During Period, Shares, New Issues (in Shares)														8,063
AJB Capital Note [Member]
Stockholders’ Equity (Deficit) (Details) [Line Items]
Common Stock, Shares, Issued (in Shares)																		91,328
Derivative Liability										$ 106,608	$ 106,608				$ 106,608				$ 106,608
Debt Instrument, Unamortized Discount																			$ 349,914
Accounts Payable [Member] | Stock Subscribed [Member]
Stockholders’ Equity (Deficit) (Details) [Line Items]
Debt Conversion, Original Debt, Amount											$ 95,558
Series A Preferred Stock [Member]
Stockholders’ Equity (Deficit) (Details) [Line Items]
Preferred Stock, Shares Authorized (in Shares)														500,000
Preferred Stock, Par or Stated Value Per Share (in Dollars per share)														$ 0.01			$ 0.01
Preferred Stock, Shares Outstanding (in Shares)														0			0
Series A Preferred Stock [Member] | The Good Clinic [Member]
Stockholders’ Equity (Deficit) (Details) [Line Items]
Preferred Stock, Dividend Rate, Percentage														10.00%
Series C Preferred Stock [Member]
Stockholders’ Equity (Deficit) (Details) [Line Items]
Preferred Stock, Shares Authorized (in Shares)														3,000,000
Dividends, Preferred Stock														$ 16,521	16,395
Preferred Stock, Par or Stated Value Per Share (in Dollars per share)														$ 0.01			$ 0.01
Preferred Stock, Shares Outstanding (in Shares)														1,047,619			1,047,619
Series D Preferred Stock [Member]
Stockholders’ Equity (Deficit) (Details) [Line Items]
Preferred Stock, Shares Authorized (in Shares)														10,000,000
Dividends, Preferred Stock														$ 48,156	48,156
Preferred Stock, Par or Stated Value Per Share (in Dollars per share)														$ 0.01			$ 0.01
Preferred Stock, Shares Outstanding (in Shares)														3,100,000			3,100,000
Series E Preferred Stock [Member]
Stockholders’ Equity (Deficit) (Details) [Line Items]
Preferred Stock, Shares Authorized (in Shares)								10,000						10,000
Preferred Stock, Liquidation Preference Per Share (in Dollars per share)								$ 1,000
Preferred Stock, Par or Stated Value Per Share (in Dollars per share)								$ 0.01
Series F Preferred Stock [Member]
Stockholders’ Equity (Deficit) (Details) [Line Items]
Preferred Stock, Shares Authorized (in Shares)		140,000												140,000
Preferred Stock, Liquidation Preference Per Share (in Dollars per share)		$ 1,000
Preferred Stock, Par or Stated Value Per Share (in Dollars per share)		$ 0.01
Preferred Stock, Convertible, Terms		The Series F can be converted, at the option of the Series F shareholder into shares of the Company’s common stock at a price equal to 65% of the Volume Weighted Average Price ("VWAP”) on the conversion date. No conversions can occur until the Company has successfully completed an uplist to NASDAQ.
Series X Preferred Stock [Member]
Stockholders’ Equity (Deficit) (Details) [Line Items]
Preferred Stock, Shares Authorized (in Shares)														27,324
Dividends, Preferred Stock														$ 15,141	15,141
Preferred Stock, Liquidation Preference Per Share (in Dollars per share)														$ 25
Preferred Stock, Par or Stated Value Per Share (in Dollars per share)														$ 0.01			$ 0.01
Preferred Stock, Shares Outstanding (in Shares)														24,227			24,227
Preferred Stock, Dividend Payment Terms														The Company reserves the right to pay the dividends in shares of the Company’s common stock at a price equal to the average closing price over the five days prior to the date of the dividend declaration.
Preferred Stock, Voting Rights														Each one share of the Series X Preferred Stock is entitled to 20,000 votes on all matters submitted to a vote of our shareholders.
Waiver Fee [Member]
Stockholders’ Equity (Deficit) (Details) [Line Items]
Stock Issued During Period, Shares, Other (in Shares)										30,834
Other Noncash Expense																$ 385,431
																$ 198,273
Share-Based Payment Arrangement, Option [Member]
Stockholders’ Equity (Deficit) (Details) [Line Items]
Share-Based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount														$ 2.1
Officer [Member] | Series X Preferred Stock [Member]
Stockholders’ Equity (Deficit) (Details) [Line Items]
Stock Issued During Period, Shares, New Issues (in Shares)														1,066
Officer [Member] | Series X Preferred Stock [Member]
Stockholders’ Equity (Deficit) (Details) [Line Items]
Dividends, Preferred Stock														$ 2,000	2,000
Majority Shareholder [Member] | Series X Preferred Stock [Member]
Stockholders’ Equity (Deficit) (Details) [Line Items]
Stock Issued During Period, Shares, New Issues (in Shares)														4,160
Majority Shareholder [Member] | Series X Preferred Stock [Member]
Stockholders’ Equity (Deficit) (Details) [Line Items]
Dividends, Preferred Stock														$ 7,814	8,000
Nonrelated Party [Member]
Stockholders’ Equity (Deficit) (Details) [Line Items]
Dividends, Preferred Stock														$ 61,823	61,695
Nonrelated Party [Member] | Series X Preferred Stock [Member]
Stockholders’ Equity (Deficit) (Details) [Line Items]
Stock Issued During Period, Shares, New Issues (in Shares)														2,837
Nonrelated Party [Member] | Series X Preferred Stock [Member]
Stockholders’ Equity (Deficit) (Details) [Line Items]
Dividends, Preferred Stock														$ 5,327	$ 6,000
Gardner Agreement [Member]
Stockholders’ Equity (Deficit) (Details) [Line Items]
Debt Instrument, Convertible, Conversion Price (in Dollars per share)													$ 12.5
Debt Conversion, Converted Instrument, Amount													$ 500,000
Other Accrued Liabilities, Current													$ 294,912
Gardner Agreement [Member] | Restricted Stock [Member]
Stockholders’ Equity (Deficit) (Details) [Line Items]
Debt Conversion, Converted Instrument, Shares Issued (in Shares)													63,593
AJB Capital Investors [Member]
Stockholders’ Equity (Deficit) (Details) [Line Items]
Stock Issued During Period, Shares, Other (in Shares)											34,400
Contract, Price per share (in Dollars per share)											$ 12.5
Adjustments to Additional Paid in Capital, Other											$ 226,106
AJB Capital Investors [Member] | Valuation, Market Approach [Member]
Stockholders’ Equity (Deficit) (Details) [Line Items]
Shares Issued, Price Per Share (in Dollars per share)										$ 6.14	$ 6.14				$ 6.14
AJB Capital Investors [Member] | Warrant and Commitment Fees [Member] | AJB Capital Note [Member]
Stockholders’ Equity (Deficit) (Details) [Line Items]
Debt Instrument, Unamortized Discount										$ 349,914	$ 349,914				$ 349,914